CD38 Deficiency Alleviates Diabetic Cardiomyopathy by Coordinately Inhibiting Pyroptosis and Apoptosis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242116008 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ling-Fang Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchan…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetic Cardiomyopathies, Sirtuin 3. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and development Program of China, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Diabetic cardiomyopathy is one of the diabetes mellitus-induced cardiovascular complications that can result in heart failure in severe cases, which is characterized by cardiomyocyte apoptosis, local inflammation, oxidative stress, and myocardial fibrosis. CD38, a main hydrolase of NAD+ in mammals, plays an important role in various cardiovascular diseases, according to our previous studies. However, the role of CD38 in diabetes-induced cardiomyopathy is still unknown. Here, we report that global deletion of the CD38 gene significantly prevented diabetic cardiomyopathy induced by high-fat diet plus streptozotocin (STZ) injection in CD38 knockout (CD38-KO) mice. We observed that CD38 expression was up-regulated, whereas the expression of Sirt3 was down-regulated in the hearts of diabetic mice. CD38 deficiency significantly promoted glucose metabolism and improved cardiac functions, exemplified by increased left ventricular ejection fraction and fractional shortening. In addition, we observed that CD38 deficiency markedly decreased diabetes or high glucose and palmitic acid (HG + PA)-induced pyroptosis and apoptosis in CD38 knockout hearts or cardiomyocytes, respectively. Furthermore, we found that the expression levels of Sirt3, mainly located in mitochondria, and its target gene FOXO3a were increased in CD38-deficient hearts and cardiomyocytes with CD38 knockdown under diabetic induction conditions. In conclusion, we demonstrated that CD38 deficiency protected mice from diabetes-induced diabetic cardiomyopathy by reducing pyroptosis and apoptosis via activating NAD+/Sirt3/FOXO3a signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and development Program of China
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Wang, L. F., Li, Q., Wen, K., Zhao, Q. H., Zhang, Y. T., Zhao, J. L., Ding, Q., Guan, X. H., Xiao, Y. F., Deng, K. Y., & Xin, H. B. (2023). CD38 Deficiency Alleviates Diabetic Cardiomyopathy by Coordinately Inhibiting Pyroptosis and Apoptosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242116008
Vancouver
Wang LF, Li Q, Wen K, Zhao QH, Zhang YT, Zhao JL, et al. CD38 Deficiency Alleviates Diabetic Cardiomyopathy by Coordinately Inhibiting Pyroptosis and Apoptosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242116008
BibTeX
@article{Wang2023,
author = {Wang, Ling-Fang and Li, Qian and Wen, Ke and Zhao, Qi-Hang and Zhang, Ya-Ting and Zhao, Jia-Le and Ding, Qi and Guan, Xiao-Hui and Xiao, Yun-Fei and Deng, Ke-Yu and Xin, Hong-Bo},
title = {CD38 Deficiency Alleviates Diabetic Cardiomyopathy by Coordinately Inhibiting Pyroptosis and Apoptosis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242116008}
}
EUVIMED